Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

Vaccinations

Vaccinations

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Total laparoscopic retrieval of a cava filter: case series].

Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery·2020

Same author

[Head surgery in the pictorial art of the past].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko·2019

Same author

[Cryoablation in urology].

Urologiia (Moscow, Russia : 1999)·2015

Same author

[The development and testing of a molecular biological test system for DNA detection of anthrax pathogen by real-time polymerase chain reaction assay].

Klinicheskaia laboratornaia diagnostika·2011

Same author

[Comparative studies of microbial strains used in biotechnology for the elaboration of biosafety standards].

Vestnik Rossiiskoi akademii meditsinskikh nauk·2011

Same author

[Validation of the modified algorithm for predicting host susceptibility to viruses taking into account susceptibility parameters of primary target cell cultures and natural immunity factors].

Vestnik Rossiiskoi akademii meditsinskikh nauk·2010

Search research articles

Related Experiment Video

Updated: Jul 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

[Hepatitis B vaccine improvement].

M N Boĭchenko, A A Vorob'ev, M V Donin

Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii

|February 15, 2007

Summary

Researchers are reviewing ongoing studies to improve current hepatitis B vaccines and create new therapeutic vaccines for chronic hepatitis B treatment, enhancing immune response and patient outcomes.

Area of Science:

Hepatitis B research
Vaccinology
Immunology

Context:

Licensed hepatitis B vaccines exist but require improvement.
Chronic hepatitis B infection remains a significant global health challenge.
Therapeutic vaccines are needed for effective treatment.

Purpose:

To review current research aimed at enhancing the efficacy and immunogenicity of existing hepatitis B vaccines.
To examine the development of novel therapeutic vaccines for treating chronic hepatitis B infection.
To provide an overview of advancements in hepatitis B vaccine technology.

Summary:

This review synthesizes data on strategies to boost the effectiveness and immune-stimulating properties of licensed hepatitis B vaccines.
It also covers the progress in creating new therapeutic vaccines designed to treat individuals with chronic hepatitis B.

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Experiment Videos

Last Updated: Jul 17, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

The focus is on ongoing research and development in the field.

Impact:

Potential for improved prevention of hepatitis B virus (HBV) infection.
Advancements in treatment options for chronic HBV carriers.
Contribution to the global effort to eliminate hepatitis B as a public health problem.